Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 25.91
(0.0%)
USD 25.91
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 189.1 Million NZD | 29.7% |
| 2023 | 145.8 Million NZD | 39.79% |
| 2022 | 104.3 Million NZD | -11.91% |
| 2021 | 118.4 Million NZD | -13.07% |
| 2020 | 136.2 Million NZD | 57.82% |
| 2019 | 86.3 Million AUD | 4.73% |
| 2018 | 82.4 Million AUD | 34.99% |
| 2017 | 61.04 Million AUD | -3.32% |
| 2016 | 63.13 Million AUD | -3.6% |
| 2015 | 65.49 Million AUD | -40.11% |
| 2014 | 109.35 Million AUD | -18.71% |
| 2013 | 134.52 Million AUD | 17.24% |
| 2012 | 114.74 Million AUD | 15.85% |
| 2011 | 99.04 Million AUD | 17.76% |
| 2010 | 84.11 Million AUD | -30.46% |
| 2009 | 120.95 Million AUD | 40.46% |
| 2008 | 86.11 Million AUD | 110.83% |
| 2007 | 40.84 Million AUD | 71.32% |
| 2006 | 23.84 Million AUD | 195.61% |
| 2005 | 8.06 Million AUD | -1.36% |
| 2004 | 8.17 Million AUD | 163.23% |
| 2003 | 3.1 Million AUD | -65.39% |
| 2002 | 8.97 Million AUD | -12.78% |
| 2001 | 10.28 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 189.1 Million NZD | 29.7% |
| 2024 Q4 | 189.1 Million NZD | 0.0% |
| 2024 Q2 | 323.4 Million NZD | 14.87% |
| 2024 Q1 | 281.53 Million NZD | 93.1% |
| 2023 Q4 | 145.8 Million NZD | 21.45% |
| 2023 FY | 145.8 Million NZD | 39.79% |
| 2023 Q1 | 138.21 Million NZD | 32.52% |
| 2023 Q2 | 167.7 Million NZD | 21.33% |
| 2023 Q3 | 120.04 Million NZD | -28.42% |
| 2022 Q4 | 104.3 Million NZD | 0.0% |
| 2022 FY | 104.3 Million NZD | -11.91% |
| 2021 Q4 | 118.4 Million NZD | 0.0% |
| 2021 FY | 118.4 Million NZD | -13.07% |
| 2020 Q4 | 136.2 Million NZD | 0.0% |
| 2020 FY | 136.2 Million NZD | 57.82% |
| 2019 Q4 | 86.3 Million AUD | 0.0% |
| 2019 FY | 86.3 Million AUD | 4.73% |
| 2018 FY | 82.4 Million AUD | 34.99% |
| 2018 Q4 | 82.4 Million AUD | 0.0% |
| 2017 Q4 | 61.04 Million AUD | 0.0% |
| 2017 FY | 61.04 Million AUD | -3.32% |
| 2016 FY | 63.13 Million AUD | -3.6% |
| 2016 Q4 | 63.13 Million AUD | 0.0% |
| 2015 FY | 65.49 Million AUD | -40.11% |
| 2015 Q4 | 65.49 Million AUD | 0.0% |
| 2014 Q4 | 109.35 Million AUD | 0.0% |
| 2014 FY | 109.35 Million AUD | -18.71% |
| 2013 FY | 134.52 Million AUD | 17.24% |
| 2013 Q4 | 134.52 Million AUD | 0.0% |
| 2012 Q4 | 114.74 Million AUD | 0.0% |
| 2012 FY | 114.74 Million AUD | 15.85% |
| 2011 Q4 | 99.04 Million AUD | 0.0% |
| 2011 FY | 99.04 Million AUD | 17.76% |
| 2010 Q4 | 84.11 Million AUD | 0.0% |
| 2010 FY | 84.11 Million AUD | -30.46% |
| 2009 FY | 120.95 Million AUD | 40.46% |
| 2009 Q4 | 120.95 Million AUD | 0.0% |
| 2008 FY | 86.11 Million AUD | 110.83% |
| 2008 Q4 | 86.11 Million AUD | 0.0% |
| 2007 Q4 | 40.84 Million AUD | 0.0% |
| 2007 FY | 40.84 Million AUD | 71.32% |
| 2006 FY | 23.84 Million AUD | 195.61% |
| 2006 Q4 | 23.84 Million AUD | 0.0% |
| 2005 FY | 8.06 Million AUD | -1.36% |
| 2005 Q4 | 8.06 Million AUD | 0.0% |
| 2004 Q4 | 8.17 Million AUD | 0.0% |
| 2004 FY | 8.17 Million AUD | 163.23% |
| 2003 Q4 | 3.1 Million AUD | 0.0% |
| 2003 FY | 3.1 Million AUD | -65.39% |
| 2002 FY | 8.97 Million AUD | -12.78% |
| 2001 FY | 10.28 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -37720.0% |
| Ansell Limited | 855.59 Million USD | 77.898% |
| Ansell Limited | 857.2 Million USD | 77.94% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -743.761% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -903172.032% |
| Psykey, Inc. | 1.01 Million USD | -18611.656% |
| ConvaTec Group Plc | 1.31 Billion USD | 85.571% |
| ConvaTec Group Plc | 1.31 Billion USD | 85.591% |
| Encision Inc. | 1.33 Million USD | -14083.897% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -8090.696% |
| Innovative MedTech Inc. | 1.87 Million USD | -9968.016% |
| LifePoint, Inc. | 446.74 Thousand USD | -42228.871% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -3405.629% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -8538.648% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -77833.104% |
| SmileDirectClub, Inc. | 871.79 Million USD | 78.309% |
| Sector 10, Inc. | 164 Thousand USD | -115204.878% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 71.944% |
| SheerVision, Inc. | 75 Thousand USD | -252033.333% |
| United Health Products, Inc. | 755.98 Thousand USD | -24913.591% |
| Vasamed, Inc. | 23.45 Thousand USD | -806296.588% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -6733.203% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -23821.599% |